69 related articles for article (PubMed ID: 19102214)
1. [The role of PET in the diagnosis and prediction of the treatment response in patients with cervical carcinoma treated with radiotherapy--results of pilot study].
Dolezelová H; Slampa P; Ondrová B; Bolcák K; Gombosová J; Sovadinová S; Novotný T; Růzicková J; Hynková L; Opletal P; Forbelská M
Klin Onkol; 2008; 21(2):66-70. PubMed ID: 19102214
[TBL] [Abstract][Full Text] [Related]
2. The impact of PET with 18FDG in radiotherapy treatment planning and in the prediction in patients with cervix carcinoma: results of pilot study.
Dolezelova H; Slampa P; Ondrova B; Gombosova J; Sovadinova S; Novotny T; Bolcak K; Ruzickova J; Hynkova L; Forbelska M
Neoplasma; 2008; 55(5):437-41. PubMed ID: 18665755
[TBL] [Abstract][Full Text] [Related]
3. [The impact of PET in radiotherapy of the cervical carcinoma--results of pilot study].
Dolezelová H; Slampa P; Bolcák K; Gombosová J; Ondrová B; Novotný T; Hynková L; Růzicková J; Forbelská M
Ceska Gynekol; 2008 Jun; 73(3):135-40. PubMed ID: 18646663
[TBL] [Abstract][Full Text] [Related]
4. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
Yildirim Y; Sehirali S; Avci ME; Yilmaz C; Ertopcu K; Tinar S; Duman Y; Sayhan S
Gynecol Oncol; 2008 Jan; 108(1):154-9. PubMed ID: 17945337
[TBL] [Abstract][Full Text] [Related]
5. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
[TBL] [Abstract][Full Text] [Related]
6. [Use of PET/CT examination in head and neck cancer radiotherapy planning].
Kolárová I; Vanásek J; Odrázka K; Petruzelka L; Dolezel M; Nechvíl J
Klin Onkol; 2009; 22(3):98-103. PubMed ID: 19708543
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
Chao A; Ho KC; Wang CC; Cheng HH; Lin G; Yen TC; Lai CH
Gynecol Oncol; 2008 Aug; 110(2):172-8. PubMed ID: 18499238
[TBL] [Abstract][Full Text] [Related]
8. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
[TBL] [Abstract][Full Text] [Related]
9. Role of PET/CT in the evaluation of cervical cancer.
Jover R; Lourido D; Gonzalez C; Rojo A; Gorospe L; Alfonso JM
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S55-9. PubMed ID: 18667229
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET in cervical cancer: staging, re-staging and follow-up.
Bjurberg M; Kjellén E; Ohlsson T; Ridderheim M; Brun E
Acta Obstet Gynecol Scand; 2007; 86(11):1385-91. PubMed ID: 17851810
[TBL] [Abstract][Full Text] [Related]
11. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study.
Chatterjee S; Frew J; Mott J; McCallum H; Stevenson P; Maxwell R; Wilsdon J; Kelly CG
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e173-9. PubMed ID: 23079100
[TBL] [Abstract][Full Text] [Related]
12. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutch DG; Powell MA; Grigsby PW
J Clin Oncol; 2010 Apr; 28(12):2108-13. PubMed ID: 20308664
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.
Sakurai H; Suzuki Y; Nonaka T; Ishikawa H; Shioya M; Kiyohara H; Katoh H; Nakayama Y; Hasegawa M; Nakano T
Gynecol Oncol; 2006 Mar; 100(3):601-7. PubMed ID: 16257440
[TBL] [Abstract][Full Text] [Related]
14. 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.
Schwarz JK; Lin LL; Siegel BA; Miller TR; Grigsby PW
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1502-7. PubMed ID: 18538498
[TBL] [Abstract][Full Text] [Related]
15. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
Wright JD; Dehdashti F; Herzog TJ; Mutch DG; Huettner PC; Rader JS; Gibb RK; Powell MA; Gao F; Siegel BA; Grigsby PW
Cancer; 2005 Dec; 104(11):2484-91. PubMed ID: 16270319
[TBL] [Abstract][Full Text] [Related]
16. Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy.
Chung HH; Park NH; Kim JW; Song YS; Chung JK; Kang SB
Gynecol Obstet Invest; 2009; 67(1):61-6. PubMed ID: 18843187
[TBL] [Abstract][Full Text] [Related]
17. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
18. Correlation between [18f]fluorodeoxyglucose positron-emission tomography scan and histology of pelvic nodes in early-stage cervical cancer.
Bentivegna E; Uzan C; Gouy S; Leboulleux S; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
Anticancer Res; 2010 Mar; 30(3):1029-32. PubMed ID: 20393032
[TBL] [Abstract][Full Text] [Related]
19. Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix.
Lin LL; Mutic S; Malyapa RS; Low DA; Miller TR; Vicic M; Laforest R; Zoberi I; Grigsby PW
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1494-501. PubMed ID: 16154713
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.
Chung HH; Jo H; Kang WJ; Kim JW; Park NH; Song YS; Chung JK; Kang SB; Lee HP
Gynecol Oncol; 2007 Mar; 104(3):529-34. PubMed ID: 17049971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
